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Abstract
Background: Our study objective was to determine the validity and reliability of the breast module of a cancer
awareness measure (BCAM) among adult women in western Kenya.
Methods: The study was conducted between October and November 2012, following three breast cancer screening
events. Purposive and systematic random sampling methods were used to identity 48 women for cognitive focus
group discussions, and 1061 (594 who attended vs. 467 who did not attend screening events) for surveys, respectively.
Face and psychometric validity of the BCAM survey was assessed using cognitive testing, factor analysis of survey data,
and correlations. Internal reliability was assessed using Cronbach’s alpha.
Results: Among survey participants, the overall median age was 34 (IQR: 26–44) years. Compared to those women who
did not attend the screening events, women attendees were older (median: 35 vs. 32 years, p = 0.001) more often
married (79% vs. 72%, p = 0.006), more educated (52% vs. 46% with more than an elementary level of education,
p = 0.001), more unemployed (59% vs. 11%, p = 0.001), more likely to report doing breast self-examination (56%
vs. 40%, p = 0.001) and more likely to report having felt a breast lump (16% vs. 7%, p = 0.001). For domain 1 on
knowledge of breast cancer symptoms, one factor (three items) with Eigen value of 1.76 emerged for the group
that did not attend screening, and 1.50 for the group that attended screening. For both groups two factors (factor 1
“internal influences” and factor 2 “external influences”) emerged among domain 4 on barriers to screening, with varied
item loadings and Eigen values. There were no statistically significant differences in the factor scores between attendees
and non-attendees. There were significant associations between factor scores and other attributes of the
surveyed population, including associations with occupation, transportation type, and training for and practice of breast
self-examination. Cronbach’s alpha showed an acceptable internal consistency.
Conclusion: Certain subpopulations are less likely than others to attend breast screening in Kenya. A survey measure of
breast cancer knowledge and perceived barriers to screening shows promise for use in Kenya for characterizing clinical
and community population beliefs, but needs adaptation for setting, language and culture.
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Background
Among all cancers, breast cancer has the highest cancer-
related morbidity and mortality rates in sub-Saharan Africa
[1–4], and these rates are on the rise [2]. It is reported that
70–90% of the women affected by breast cancer in this
region present with late-stage disease with poor outcomes
as a result [4]. Even though approaches to enhancing early
diagnosis and treatment have been advocated [3, 5], the
region is faced with a number of challenges to achieving
earlier diagnosis and care, including limited funds for
health care services, underfunded health care facilities,
lack of mammography equipment, and low levels of
community awareness of breast cancer [3–7]. Taken
together, these limitations have had a major adverse
impact on efforts to reduce the stage at which breast
cancer is diagnosed and treated.
In spite of these many challenges, screening programs
that feature self and clinician breast exams as well as
mammograms (where available) have been advocated as
important stepping stones to promote public awareness,
timely diagnosis and treatment and cancer prevention
[2, 5]. Even when preventive services are available, however,
community participation in these activities has been
variable and limited. Breast cancer screening uptake in
developed countries has been associated with factors
such as being older in age, married, having a higher
socio-economic status, more physician endorsement
and having a higher social status [8]. Unfortunately, there is
little or no comparable information in resource-scarce envi-
ronments in sub-Saharan Africa. In the context of initial
efforts to develop appropriate approaches to breast cancer
screening in western Kenya, we felt the need to have a
better understanding of the levels of public awareness,
perceptions of breast cancer, and screening practices in
various communities served by a health care delivery
system. If a well-formed and valid survey instrument
could be developed to characterize these matters, we
believed that educational programs for the public could
be focused to fill gaps in knowledge and perhaps stimu-
late greater volunteerism for screening.
Contemplating the use of a questionnaire that could
be used to characterize citizen opinions of relevance to
breast cancer screening, we unfortunately found no vali-
dated scales that had been field-tested in a Kenyan popula-
tion. The literature however revealed that a number of
validated scales had been developed for North American or
European populations [8–11], scales whose psychometric
properties would need to be evaluated if we were to adapt
them for use in a Kenyan population. The value of assessing
the psychometric properties of a scale to determine its
validity and reliability within a specific cultural setting
cannot be overstated [12, 13]. Cross-cultural and language
differences routinely introduce measurement biases that
affect the quality of data collected [12, 13].
After review of measures, we adopted a validated breast
module of cancer awareness measure (BCAM), originally
developed to determine level of cancer awareness and
associated factors for the UK population [11]. The BCAM
was attractive to us because it included measures of breast
cancer awareness and perceived barriers to breast cancer
screening. Our system’s oncologists considered both of
these cognitive domains to constitute major impediments
to timely screening for the detection of early-stage breast
cancer. In UK populations, BCAM readability had been
found to be high and the measure was acceptable to
women. Construct validity was supported by significant
differences between the levels of cancer awareness among
cancer professionals compared to non-medical academics
(50% vs. 6%, p = 0.001) attending cancer screening
programs [11].
In order to the use the BCAM in western Kenya,
collaborative research group (the Walther Project group)
believed that new descriptive work to assess the psy-
chometric characteristics of the BCAM should be car-
ried out. Our overall study objectives were to assess the
face validity, language appropriateness and internal reli-
ability of the BCAM among adult women in western
Kenya. We were also interested in exploratory factor
analyses to discover any internal structure within the
data from BCAM when administered to our catchment
area populations. In psychometrics, ‘internal structure’
refers to a pattern of responses to items in a questionnaire.
Items that cohere together illuminate the instrument’s
dimensionality. In this communication, we report the pro-
cedures and findings of our work as a potential guide to
others undertaking analogous work.
Methods
Study site
Although collaboration in health care, education and
research had linked Indiana University School of Medicine
and its Kenyan partners since 1989, the health care delivery
system Academic Model Providing Access to Healthcare
(AMPATH) was not formally designated until 2001 as a
joint partnership among Moi University School of Medicine,
the Moi Teaching and Referral Hospital, the Kenyan
Ministry of Health and a consortium of North American
medical schools lead by Indiana University School of
Medicine [14]. The initial goal of AMPATH was to estab-
lish an HIV care delivery system to serve the needs of both
urban and rural patients. The program operates now in 25
Ministry of Health facilities with numerous satellite clinics
in a large geographic area of western Kenya. Over the
years since 2001, AMPATH has expanded its mission to
embrace primary health care and chronic disease manage-
ment, including the prevention and care of cancer. The
AMPATH Oncology Institute (AOI) was developed from
the platform of the HIV-care program to address the care
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of cancer patients, for whom there were limited treatment
options available. AOI has evolved over time with the first
services being pediatric oncology, which transitioned into
care for AIDS-related malignancies, then to broad-based
cancer treatment services, and most recently, a formally
structured model for rationed care commensurate with
the resource constraints and population burden of
western Kenya [9]. Within the AOI, the “Walther project”
was initiated in 2011 when a grant was made by the
Walther Cancer Foundation (“The IU Simon Cancer
Center (IUSCC), AMPATH-Oncology Institute (AOI):
An Exemplar of Care for the Developing World and a
Population-based Research Environment for IUSCC”)
in support of cancer research in Kenya. The Walther
project has focused on cancer prevention activities and
their evaluation, especially activities that respond to
challenges in the AMPATH service area in western Kenya
posed by breast and cervical cancer.
The Walter project personnel, working in collaboration
with the AMPATH oncology team, conducted free breast
cancer screening events in October-November of 2012 at
three AMPATH sites – Mosoriot (one-day event), Turbo
(two-day event), and Kapsokwony (two-day event). In the
absence of mammography availability, the screening
services offered were clinician breast examination by
health care providers (physician-oncologists). All screening
events were held at the Ministry of Health centers in
the respective sites. One week before the events, posters,
community meetings (mabaraza), and word-of-mouth
information dissemination through community health
workers were used to publicize the screening events
and to invite community member participation. While
the aim of the screening events was to screen otherwise
healthy women, individuals who were found to have a
breast mass were given a return date when biopsies
could be done to determine whether they had breast
cancer. Care for those with cancer was provided at the
western Kenyan national referral facility in Eldoret
(Moi Teaching and Referral Hospital).
Study design
BCAM study surveys were conducted in October and
November 2012, following three breast cancer screening
events. The study was completed in three phases: 1)
focus group cognitive interviews preceding the use of
the BCAM, 2) health facility screening event participant
surveys with the revised BCAM, and 3) household sur-
veys with the revised BCAM in the catchment service
areas of the health centers. We targeted women 18 years
and older from the respective communities. Purposive
sampling was used to identify participants (community
women) for the cognitive interviews that were con-
ducted in 6 focus group discussions (FGDs), with an
average of 8 participants per group. The health facility
survey included respondents who attended the screening
events, while the household survey was conducted one day
after the screening events and targeted community women
who had not attended the screening. Any women in house-
holds who reported they had attended the previous day’s
screening event were ineligible for the community survey.
For the health facility-based survey, systemic random
sampling was used to solicit participation among women
waiting to be screened. We randomly selected the first
person and thereafter every third person as they presented
themselves for screening. A total of 1238 women were
screened and 594 (48% of total screening attendees) con-
senting women were recruited for the household survey.
Similarly, systematic random sampling with replacement
method was used to identify the study sample for the
household survey. We approached random households
along all access routes that extended from each health
center into its surrounding community. All 467 women
recruited for the household survey, provided written
consent and participated in the study. The survey re-
search assistants, however, did not assess household
census information so we are unable to directly report
true community-based participation rates for women.
Approval for this study was obtained from the Moi
University Institutional Research and Ethics Committee
(IREC) as well as the Indiana University Institutional
Review Board (IRB).
Instrument refinement
For instrument refinement, we adopted the BCAM ques-
tionnaire content that included demographic factors plus
question items in 7 domains: (1) knowledge of symptoms;
(2) confidence, skills and behavior in relation to breast
changes; (3) anticipated delay in contacting the doctor; (4)
barriers to seeking medical help; (5) knowledge of
age-related and lifetime risk; (6) knowledge of breast
screening; and (7) knowledge of risk factors for breast
cancer. The questionnaire was then translated to Swahili.
Findings from the cognitive interview were used to revise
the items for clarity. For this study report we focused on
the psychometric analysis of items in exemplar domains 1
and 4 (knowledge and perceived barriers) as shown in
Table 1.
Cognitive interviews
These interviews took place in 6 FGDs with an average
of 8 individuals per group. FGDs have been previously
used as a cognitive interviewing approach to explore the
understanding of items [15]. The interviews focused on
comprehension of item stems and response formats for
each item in the study instrument domains. This process
aimed at identifying and eliminating measurement errors
that might be associated with comprehension, judgment,
recall, and reporting biases. FGD guide probes included
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components of think aloud, comprehension retrieval,
judgment, and response. Cognitive interview recordings
were transcribed verbatim, translated from Swahili to
English, and coded for themes. Themes identified highlighted
areas of concern with the scale. Revisions of the items
triggered by FGD findings were made without changing
the focus and meaning of the items.
Study procedure
After changes driven by cognitive interviewing, the revised
survey was administered to our target women populations
in one of two languages (either English or Swahili) by
trained research personnel. Written consent was obtained
from all participants prior to their participation in the
study. The health facility survey was administered to
eligible individuals prior to screening at the respective
health facilities while the household survey was adminis-
tered in the household one day after the screening event.
Both surveys had the same BCAM questions.
Data analyses
For the surveys, analysis was performed using STATA
version 12 special edition. Categorical variables were sum-
marized as frequencies and the corresponding percent
distributions while continuous variables, which were estab-
lished to have skewed distribution, were summarized as
Table 1 Domain 1 and Domain 4 of the BCAM instrument
Domain 1: Knowledge of breast cancer symptoms Yes No Don’t know Refused
Do you think a change in the position of your nipple could be a sign of breast cancer?
(Explanation: Such as pointing up or down or in a different direction to normal).
NB: Use the labeled picture of the breast as necessary
Do you think pulling in of your nipple could be a sign of breast cancer?
(Explanation: Where the nipple no longer points outwards, but into the breast)
Do you think pain in one of your breasts could be a sign of breast cancer?
Do you think puckering or dimpling of your breast skin could be a sign of breast cancer?
(Explanation: Like a dent or orange peel appearance.)
NB: Use the labeled picture of the breast as necessary
Do you think abnormal discharge from your nipple could be a sign of breast cancer?
Do you think bleeding from your nipple could be a sign of breast cancer?
Do you think a lump in your breast could be a sign of breast cancer?
Do you think a nipple rash could be a sign of breast cancer?
Do you think if your breasts change skin color, this could be a sign of breast cancer?
Do you think a lump under your armpit could be a sign of breast cancer?
Do you think changes in the size of your breast could be signs of breast cancer?
Do you think changes in the size of your nipple could be signs of breast cancer?
Do you think changes in the shape of your breast could be signs of breast cancer?
NB: Pictures of different shapes of breasts will be provided
Domain 4: Barriers to screening Yes often Yes sometimes No Don’t know
Would you be too embarrassed to go and see the doctor?
Would you be too scared to go and see the doctor?
Would you be worried about wasting the doctor’s time?
Would you find your doctor difficult to talk to?
Would it be too difficult to make an appointment with the doctor?
Would you be too busy to make time to go to the doctor?
Would seeing the doctor be too expensive and you don’t have enough money?
Would it be too difficult to arrange transport to the doctor’s clinic?
Would worrying about what the doctor might find stop you from going to the doctor?
Would not feeling confident talking about your symptom with the doctor would keep
you from seeing h/m/her.
Would significant people in your life (e.g. husband/wife, partner, sibling, relative or friend)
not approve of you seeing a doctor or nurse?
Would your doctor not understand your language?
Would your doctor not understand your culture?
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median and corresponding inter-quartile range (IQR).
Items assessing knowledge of breast cancer symptoms
items were responded to with a “yes” = 1, “don’t know” = 0,
“No” = −1 format. The resulting maximum score of 13
meant that participants had full knowledge of breast cancer
symptoms. Scoring of barriers to breast cancer screening
items was accomplished by summing item responses in a
“yes often” = 2, “yes sometime” = 1, “non-response or don't
know or refused” = 0 format. A maximum score of 28 was
possible if the participants affirmed the highest number of
perceived barriers. The test for normality was performed
using the Shapiro-Wilks test. The test for associations was
conducted using Pearson’s Chi Square (for categorical
variables) and two-sample Wilcoxon rank sum test (for
continuous and categorical variables).
Principal factoring method was performed on the items
assessing knowledge of breast cancer symptoms and bar-
riers to screening. Prior to factor analysis, Barlett’s test for
sphericity as well as the Kaiser-Meyer-Olkin’s measure for
sampling adequacy were done. The factors extracted were
based on the Kaiser’s rule (Eigen values >1) which states
that only the factors that have eigenvalues greater than one
are retained for interpretation [16]. The factor loadings of
the extracted factors were orthogonally rotated using the
varimax method. The initial communalities were specified
to be the squared multiple correlations (SMCs). After factor
analysis, factor scores were computed (predicted factors)
based on the factors extracted. The association between the
factor scores and the categorical variables was explored
using a simple linear regression model and Pearson product
moment correlation for continuous variables. In addition,
internal consistency of the scale was assessed using
Cronbach’s alpha.
Results
Participant characteristics
A total of 1061 women participated in surveys, including
594 women who attended the breast cancer screening
events and 467 community women who did not attend the
events. Their overall median age was 34 (IQR: 26–44) years,
with the majority (76%) of the women being married. Half
(50%) of the women had attained more than elementary
level of education, and only 62% were employed.
As shown in Table 2, women who attended the breast
cancer screening events were older than the women who
did not attend the events. In addition, a higher proportion
of women who attended the events were married, had
attained more than elementary level of education, were
unemployed and had to walk longer distances to the health
facilities compared to those who did not attend the events.
Overall, about a half of the women had checked their
breasts for lumps (Table 2). Only 12% had actually felt a
lump, and 10% had previously undergone breast cancer
screening. About a third of the women reported having
been trained to feel their breasts for lumps. A larger
percent of the women who attended the screening events
had been trained to feel their breasts for lumps, had
previously checked their breasts for lumps and had felt
a breast lump, compared to those who did not attend
the events (Table 2).
Content validity
Cognitive testing of the original BCAM domains 1 and 4
revealed some potential biases that could have been influ-
enced by cultural differences and the translation of items
from English to Swahili. There were a number of double-
barreled questions highlighted in domain 1 that explored
knowledge of breast cancer symptoms. For example ‘Do
you think discharge or bleeding from your nipple could
be a sign of breast cancer?’ was considered in our focus
groups to be a double-barreled question because respon-
dents were confused as to whether the interviewer was
referring to any form of discharge or blood. Similarly ‘Do
you think a lump or thickening in your breast could be
a sign of breast cancer?’ ‘Do you think a lump or
thickening under your armpit could be a sign of
breast cancer?’ and ‘Do you think changes in the shape
of your breast or nipple could be signs of breast can-
cer?’ elicited the same confusion associated with double-
barreled question because of the inclusion of the conjunc-
tion ‘or’ in the statements. FGD participants recommended
avoiding ‘or’ in such questions.
Given that it might be difficult to detect redness in
dark-skinned persons, a majority of the women could
not decide how to respond to the following item; ‘Do
you think redness of your breast skin could be a sign
of breast cancer?’ They requested clarification on
whether the redness was due to peeling of the top surface
of the skin, because they could not otherwise understand
how dark skin could turn red. It was recommended that
the statement be replaced with ‘Do you think if one of
your breasts changes skin color, this could be a sign of
breast cancer?’
In addition, respondents had difficulty understanding
the statement ‘Do you think changes in the shape of
your breast or nipple could be signs of breast cancer?’
The concept of ‘shape’ was difficult for respondents to en-
vision with the majority speculating that changes in breast
‘shape’ must mean that a breast enlarges or decreases in
size, rather than a deformation of breast symmetry. It was
recommended that a pictorial representation of changes
in breast shapes be provided.
For items in domain 4 related to barriers to breast cancer
screening, we were advised in FGDs to change all the
statements to questions in order to avoid misunder-
standings that might arise because our surveys were
sometimes interviewer-administered rather than patient
self-administered.
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Factor analysis
We used factor analysis as a tool to explore the patterns
of item responses from our subpopulations, reasoning
that groups who differed in their health-seeking behaviors
(e.g. screening attendees and non-attendees) might also
differ systematically in their responses to questions about
breast cancer risk, presenting symptoms, and barriers to
screening. The output of these analyses was used as a
descriptive tool to decide whether differences in the ‘struc-
ture of knowledge and beliefs’ in our two subpopulations
could be discerned.
There were, in fact, no striking differences in the factor
loadings in the item responses from the groups of women
who attended the screening events vs. those who did not
attend the events (see Table 3 for individual item loading
and overall factor Eigen values). In domain 1 (knowledge
of breast cancer symptoms), one factor with eigenvalue of
1.50 emerged for the group that attended the screening
events. Similarly, one factor emerged with an Eigen value
of 1.76 among those who did not attend the events. These
factors contained three similar items that focused on
breast size and nipple changes. The factor loadings ranged
from 0.65 to 0.74 among those who attended the screen-
ing events, and 0.75 to 0.80 among those who did not
attend the screening events. The median factor score was
0.54 (IQR: −0.54, 0.54) with a minimum and a maximum
of −2.39 and 0.66 respectively. This meant that the women
had relatively high knowledge of breast cancer symptoms.
Factor analysis performed on items assessing barriers
to breast cancer screening (domain 4) revealed two major
factors across the study groups. Factor one included items
focused on internal influences that were reported as
barriers to screening with a median score of −0.162
(IQR: −0.163, −0.162) and a minimum and a maximum
of −0.61 and 5.94, respectively. There were five items
with factor loadings ranging from 0.54–0.84 and Eigen
value of 1.99 for the group that attended the events.
Similarly, among those who did not attend the events,
there were five items with factor loadings ranging from
0.52–0.84 and an Eigen value of 2.56 (Table 3). On the
other hand, the second factor included items focused
on external influences viewed as barriers to breast cancer
screening with a median score of −0.14 (IQR: −0.24, −0.14)
and a minimum and a maximum of −1.03 and 5.68, re-
spectively. Two items with loadings of 0.55 and Eigen
values of above 1.30 were reported in the group that
attended the events. Similarly, two items with loadings
of 0.80 and an Eigen values of greater than 0.60 emerged
from the group that did not attend the events.
We further explored measurement variance within the
two factors (internal and external barriers) by screening
uptake behaviors. Though internal knowledge influences
appeared to be higher for screening attendees than non-
attendees, on testing there were no statistically significant
differences in perceived internal (p = 0.07) and external
(p = 0.63) barriers between the two groups in factor scores.
Reliability
A Cronbach’s alpha of 0.80 and above was reported for
all the emerging factors across the two domains, except
Table 2 Participants characteristics
Variables Total (N = 1061) Attended screening
events N (%) or
median(IQR)*or
mean (SD)**
(N = 594)
Did not attend
screening events
n (%) or median(IQR)*
or mean (SD)**
(N = 467)
P Value
Age 34(26–44)* 35(28–45)* 32(25–41)* 0.001
Marital status (Married vs. other) 809(76%) 472(79%) 337(72%) 0.006
Educational level (More than elementary vs. elementary) 527(50%) 306(52%) 221(47%) 0.175
Occupation
Employed 201(19%) 130(22%) 71(15%)
Self-employed 457(43%) 114(19%) 343(74%) <0.001
Unemployed 399(38%) 347(59%) 52(11%)
Means of transport (Walking vs. other) 259(55%) 302(51%) 259(55%) 0.142
Time required to travel to the health facility (in minutes) 30(20–45)* 30(20–60)* 30(20–30)* 0.001
Check breast for lumps (Yes vs. No) 519(49%) 332(56%) 187(40%) <0.001
Having felt a breast lump (Yes vs. No) 125(12%) 94(16%) 31(7%) <0.001
Having ever undergone any breast cancer screening (Yes vs. No) 109(10%) 64(11%) 45(10%) 0.573
Having been trained how to feel for a breast lump (Yes vs. No) 296(28%) 207(35%) 89(19%) <0.001
‘-‘Analysis was not done on the respective variables
NB: Even though the median travel time to the health facility (in minutes) was similar in both groups the Wilcoxon rank-sum test assessed the dispersion between
the two groups which significantly differed for the two groups
* is for median(IQR) and ** is for mean (SD)
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for factor two within Domain 4 that reported a score of
0.60, indicating an acceptable internal consistency. How-
ever, higher scores were reported for the group that
attended the screening events in the two factors under
the barriers to screening domain compared to the group
that did not attend the screening events (Table 4).
Associations between patient characteristics and
knowledge of breast cancer symptoms and barriers to
breast cancer screening
Following the factor analysis, Table 5 shows the associ-
ation between knowledge of breast cancer symptoms
and barriers to breast cancer screening constructs with
patient characteristics. Women who did not attend the
screening events reported higher scores on knowledge
about breast cancer symptoms if they walked vs. used
other means of transport. Higher scores meant that they
had more knowledge about breast cancers symptoms.
They were also more likely to have more knowledge
about breast cancer symptoms if they had checked their
breasts for lumps and had been trained. On the other
hand, women who attended the screening events re-
ported significantly lower scores for knowledge of breast
cancer symptoms if they were self-employed vs. formally
employed. In addition, those who walked to the health
facility were more likely to report more barriers associ-
ated with external influences (Table 5).
Discussion
Breast cancer is a globally important cause of morbidity
and mortality not only in developed countries but also
in resource-scarce sub-Saharan countries where screening
and early detection programs are available [1–5, 17]. In all
settings we need to have valid measures to assess know-
ledge of breast cancer symptoms and barriers to screening
if promotion of screening and educational programming is
to advance. Our findings suggest the BCAM instrument
that was developed for the UK population [11] could be
adapted for use in a Kenyan population. Given the socio-
cultural differences between the two populations, however,
a few modifications of items intended to improve the face
validity and understandability of items as well as ex-
ploratory analysis to uncover internal instrument struc-
ture seemed warranted.
Cognitive testing of BCAM content highlighted a
number of items that could have introduced compre-
hension and reporting biases. These included double-
barreled questions, cultural interpretation differences
and translation of items to the local language, empha-
sizing the importance of cross-cultural adaptation of
measures. There were no significant differences in fac-
tor scores between the screening attendee and non-
attendee groups suggesting that these groups may not
differ in the way they perceived breast cancer symp-
toms and barriers to screening. We therefore believe
Table 3 Factor loadings
Item Attended screening
events
Did not attend screening
events
Communalities Factor
loadings
Communalities Factor
loadings
Domain 1: Knowledge of breast cancer symptoms
Factor 1
Eigen value 1.50 1.76
Do you think changes in the size of your breast could be a sign of breast cancer? 0.42 0.65 0.57 0.75
Do you think changes in the size of your nipple could be a sign of breast cancer? 0.55 0.74 0.63 0.80
Do you think changes in the shape of your breast or nipple could be signs of breast cancer? 0.53 0.73 0.56 0.75
Domain 4: Barriers to breast cancer screening
Factor 1-Internal influences
Eigen value 1.99 2.56
Would you be too embarrassed to go and see the doctor? 0.60 0.77 0.66 0.81
Would you be too scared to go and see the doctor? 0.47 0.69 0.72 0.84
Would you be worried about wasting the doctor’s time? 0.71 0.84 0.59 0.76
I find the doctor difficult to talk to 0.49 0.68 0.38 0.58
Difficult to make an appointment with the doctor 0.29 0.54 0.30 0.52
Factor 2-External influences
Eigen value 1.30 0.64
Would your doctor not understand your language? 0.32 0.55 0.64 0.80
Would your doctor not understand your culture? 0.31 0.55 0.65 0.80
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that the BCAM scale can be used in both kinds of
subpopulations.
Based on the factors that emerged in the two groups,
our findings revealed that these women had a relatively
high knowledge of breast cancer symptoms contrary to a
similar study in the UK [11]. Unfortunately this BCAM
factor in our study contained only three items focused on
breast and nipple physical changes, unlike the previous
study which used eleven items to characterize this domain
of knowledge [11]. We also noted that items affirmed in
our application of the BCAM represented symptoms of
late-stage breast cancer. Previous studies have shown that
women in this region present at the late-stage of the dis-
ease making it difficult to mitigate its adverse effects [4]. If
we are to develop an effective tool to assess and advance
breast cancer awareness in these Kenyan populations to
promote screening, there is a need to incorporate add-
itional items that comprehensively assess early-stage man-
ifestations as well as late-stage signs of breast cancer.
Internal consistency scores on the emerging factors were
found to be statistically acceptable suggesting that the
scales could be consistently used to assess knowledge of
breast cancer symptoms for those who did not attend the
events and barriers to screening for both groups.
Overall a third of the women reported having been
trained to check their breasts for lumps. It was perhaps
not surprising that compared to women who attended
screening, women who did not attend the screening
events were more knowledgeable about symptoms of
breast cancer (than those who chose to attend) and were
more likely to have been previously trained on how to
check their breast for lumps. It was, however, interesting
that among women who did not attend the screening
events, those who walked to clinic (compared to using
other means of transport) were more knowledgeable
about breast cancer symptoms. These observations are
unexplained but could imply that those who knew a lot
about the disease did not feel the need for screening,
and that women who lived close to the health facility
had more access to breast cancer information.
We noted that self-employed women who attended
screening had significantly lower knowledge of the symp-
toms of breast cancer. In this region, ‘self-employment’
usually means peasant farming or vegetable vending. This
group of individuals is often of a lower educational and
socio-economic status, conditions that could influence their
level of knowledge of breast cancer symptoms. Further
studies are needed to better understand these findings.
Generally both groups of women reported minimal
internal and external barriers to screening yet very few
women had previously attended breast cancer screening.
This suggests that uptake of breast cancer screening
Table 4 Internal consistency
Among those who did not attend screening Among those who attended screening
Item n Sign ITC IRC AIIC CA n Sign ITC IRC AIIC CA
DOMAIN 1
Do you think changes in the size of your breast could be a
sign of breast cancer?
465 + 0.86 0.69 0.65 0.79 594 + 0.81 0.57 0.61 0.76
Do you think changes in the size of your nipple could be a
sign of breast cancer?
465 + 0.88 0.73 0.59 0.74 594 + 0.85 0.65 0.51 0.67
Do you think changes in the shape of your breast or nipple
could be signs of breast cancer?
465 + 0.86 0.68 0.66 0.79 594 + 0.85 0.64 0.52 0.69
Test scale 0.63 0.84 0.55 0.80
DOMAIN 4
FACTOR 1
Would you be too embarrassed to go and see the doctor? 467 + 0.83 0.71 0.49 0.79 594 + 0.83 0.72 0.51 0.81
Would you be too scared to go and see the doctor? 467 + 0.86 0.76 0.47 0.78 594 + 0.78 0.65 0.54 0.83
Would you be worried about wasting the doctor’s time? 467 + 0.82 0.69 0.49 0.80 594 + 0.88 0.80 0.47 0.78
I find the doctor difficult to talk to 467 + 0.73 0.57 0.55 0.83 593 + 0.78 0.63 0.56 0.83
Difficult to make an appointment with the doctor 467 + 0.69 0.51 0.58 0.85 594 + 0.71 0.55 0.59 0.85
Test scale 0.51 0.84 0.53 0.85
FACTOR 2
Would your doctor not understand your language? 467 + N/A N/A 0.73 0.85 594 + N/A N/A 0.43 0.60
Would your doctor not understand your culture? 467 + N/A N/A 594 + N/A N/A
ITC item-test correlation, IRC - item-rest correlation, AIIC Average inter item correlation, CA Cronbach’s alpha
Item-test and item-rest correlations are only applicable when more than two variables are under assessment
Wachira et al. BMC Health Services Research  (2017) 17:110 Page 8 of 11
Ta
b
le
5
A
ss
oc
ia
tio
ns
be
tw
ee
n
do
m
ai
ns
af
te
r
fa
ct
or
lo
ad
in
gs
an
d
pa
tie
nt
ch
ar
ac
te
ris
tic
s
Va
ria
bl
es
A
tt
en
de
d
sc
re
en
in
g
ev
en
ts
D
id
no
t
at
te
nd
sc
re
en
in
g
ev
en
ts
Kn
ow
le
dg
e
of
br
ea
st
ca
nc
er
sy
m
pt
om
s
Fa
ct
or
1
Ba
rr
ie
rs
to
sc
re
en
in
g
Fa
ct
or
1-
In
te
rn
al
in
flu
en
ce
s
Ba
rr
ie
rs
to
sc
re
en
in
g
Fa
ct
or
2-
Ex
te
rn
al
in
flu
en
ce
s
Kn
ow
le
dg
e
of
br
ea
st
ca
nc
er
sy
m
pt
om
s
Fa
ct
or
1
Ba
rr
ie
rs
to
sc
re
en
in
g
Fa
ct
or
1-
In
te
rn
al
in
flu
en
ce
s
Ba
rr
ie
rs
to
sc
re
en
in
g
Fa
ct
or
2-
Ex
te
rn
al
in
flu
en
ce
s
A
ge
(p
er
10
ye
ar
s
in
cr
ea
se
)
0.
04
(−
0.
01
,0
.0
9)
0.
00
(−
0.
06
,0
.0
5)
0.
02
(−
0.
02
,0
.0
6)
0.
04
(−
0.
02
,0
.1
0)
0.
03
(−
0.
03
,0
.1
0)
0.
05
(−
0.
01
,0
.1
1)
M
ar
rie
d
vs
.o
th
er
s
0.
14
(−
0.
03
,0
.3
1)
0.
15
(−
0.
04
,0
.3
2)
0.
05
(−
0.
07
,0
.1
9)
0.
09
(−
0.
09
,0
.2
7)
−
0.
09
(−
0.
28
,0
.1
0)
0.
05
(−
0.
12
,0
.2
2)
O
cc
up
at
io
n
Se
lf-
em
pl
oy
ed
vs
.e
m
pl
oy
ed
−
0.
23
(−
0.
44
,−
0.
02
)
−
0.
01
(−
0.
24
,0
.2
2)
−
0.
13
(−
0.
30
,0
.0
3)
−
0.
17
(−
0.
42
,0
.0
8)
−
0.
08
(−
0.
33
,0
.1
9)
0.
08
(−
0.
16
,0
.3
2)
W
al
ki
ng
vs
.o
th
er
m
ea
ns
of
tr
an
sp
or
t
−
0.
03
(−
0.
17
,0
.1
1)
0.
01
(−
0.
14
,0
.1
6)
0.
10
(0
.0
0,
0.
20
)
0.
28
(0
.1
2,
0.
44
)
0.
00
(−
0.
17
,0
.1
7)
0.
03
(−
0.
13
,0
.1
8)
H
av
in
g
ch
ec
ke
d
br
ea
st
fo
r
lu
m
ps
0.
01
(−
0.
13
,0
.1
5)
0.
03
(−
0.
12
,0
.1
8)
−
0.
05
(−
0.
15
,0
.0
6)
0.
22
(0
.0
6,
0.
39
)
0.
02
(−
0.
15
,0
.1
9)
−
0.
04
( −
0.
20
,0
.1
1)
H
av
in
g
be
en
tr
ai
ne
d
ho
w
to
fe
el
fo
r
a
br
ea
st
lu
m
p
0.
04
(−
0.
01
,0
.1
8)
0.
04
(−
0.
11
,0
.2
0)
−
0.
02
(−
0.
13
,0
.0
9)
0.
21
(0
.0
0,
0.
41
)
−
0.
01
(−
0.
22
,0
.2
0)
−
0.
17
(−
0.
36
,0
.0
3)
Th
e
sc
or
es
re
pr
es
en
t
-r
eg
re
ss
io
n
co
ef
fic
ie
nt
(9
5%
C
I)
St
at
is
tic
al
ly
si
gn
ifi
ca
nt
sc
or
es
ar
e
in
bo
ld
Wachira et al. BMC Health Services Research  (2017) 17:110 Page 9 of 11
may be more influenced by structure or environmental
factors other than personally perceived barriers.
Based on our findings we believe that providing
adequate information about breast cancer symptoms,
how to perform self-breast exams, and how often one
should undergo breast exams by trained health providers
may promote positive behavior change and enhance screen-
ing uptake across the region. It is certainly reasonable to
offer re-examination services to women who have pre-
viously felt lumps in their breasts, but to maximize
early detection and secondary prevention, women with
no prior history of breast lumps should be motivated to
attend screening events. Survey information from asymp-
tomatic community women, such as those included in this
study, may be useful in such a motivational campaign.
This study is not without limitations. The health facility-
based survey targeted women who presented themselves
for breast cancer screening and recruited nearly half of
those in attendance to participate in the survey. Our survey
personnel did not capture information on household family
composition and participation rate in the community
survey. In the community survey, therefore, it is not
possible to measure a true population-based survey
participation rate. For these reasons, biases from different
participation rates may have influenced our findings. We
improved the BCAM items by cognitive testing and item
revision, but studies are still needed to develop appropriate
measures to assess knowledge of early stages of breast
cancer in this region.
Conclusion
In conclusion, various sub-populations in western
Kenya appear to differ in their propensity to partici-
pate in health-center based breast cancer screening.
Educational and promotional campaigns to enhance
participation in such screening will need better instru-
mentation for characterizing individual and population
knowledge and beliefs. Our findings suggest that the
BCAM instrument can be adapted for use in a Kenyan
population to assess knowledge of breast cancer symp-
toms and barriers to screening uptake. Given the cultural
differences between the UK and Kenyan populations,
however, a few modifications are needed to enhance the
performance of the measure. We believe that this study
has taken a modest step on the journey to developing a
more comprehensive, valid and reliable scale for this
Kenyan population.
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